BELLOMO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 464
AS - Asia 349
EU - Europa 334
SA - Sud America 94
AF - Africa 5
OC - Oceania 5
Totale 1.251
Nazione #
US - Stati Uniti d'America 459
SG - Singapore 142
HK - Hong Kong 121
IT - Italia 100
BR - Brasile 83
IE - Irlanda 57
DE - Germania 51
RU - Federazione Russa 47
CN - Cina 37
FI - Finlandia 27
RO - Romania 11
JP - Giappone 10
NL - Olanda 10
GB - Regno Unito 8
VN - Vietnam 7
AT - Austria 6
IN - India 6
FR - Francia 5
NZ - Nuova Zelanda 5
IQ - Iraq 4
AR - Argentina 3
BD - Bangladesh 3
CO - Colombia 3
ES - Italia 3
KR - Corea 3
TR - Turchia 3
CA - Canada 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BE - Belgio 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
TN - Tunisia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1.251
Città #
Hong Kong 120
Singapore 112
Chandler 83
Dublin 57
Boardman 56
Perugia 35
Santa Clara 31
Munich 23
Moscow 21
San Mateo 18
Los Angeles 16
Altamura 12
Helsinki 11
Turku 11
Timisoara 10
Lawrence 9
Medford 9
Princeton 9
Rome 9
Tokyo 9
Wilmington 9
Milan 8
Nuremberg 8
The Dalles 8
Dallas 7
Ashburn 6
Redmond 6
São Paulo 6
Andover 5
Auckland 5
Columbus 5
Dong Ket 5
Falls Church 5
Lappeenranta 5
Falkenstein 4
Vienna 4
Chicago 3
Des Moines 3
Groningen 3
Newark 3
Newquay 3
Phoenix 3
Secaucus 3
Seoul 3
Amsterdam 2
Beijing 2
Belém 2
Betim 2
Boston 2
Brasília 2
Brixen 2
Brooklyn 2
Córdoba 2
Genoa 2
London 2
Manchester 2
New York 2
Porto Alegre 2
Redwood City 2
Rio de Janeiro 2
Santo André 2
Seattle 2
Shanghai 2
Tashkent 2
Afyonkarahisar 1
Aktau 1
Alviano 1
Americana 1
Andradas 1
Andradina 1
Ankara 1
Ann Arbor 1
Anshan 1
Aparecida de Goiânia 1
Ariquemes 1
Aryanah 1
Baghdad 1
Bagé 1
Belo Horizonte 1
Bishkek 1
Boa Vista da Aparecida 1
Bratislava 1
Brookfield 1
Böblingen 1
Cabo Frio 1
Cabudare 1
Cachoeirinha 1
Campinas 1
Campo Grande 1
Carapicuíba 1
Caruaru 1
Carúpano 1
Casablanca 1
Changchun 1
Charlotte 1
Chattanooga 1
Chennai 1
Chisinau 1
Cincinnati 1
Ciudad del Este 1
Totale 857
Nome #
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 84
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 74
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 71
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 62
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 61
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 52
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 50
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid 49
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? 48
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 45
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 44
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 42
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview 40
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 36
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 36
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 34
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 33
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 31
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 31
Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease 31
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 30
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 28
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 28
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias 26
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 25
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions 25
Lipoproteins and α-synuclein in cerebrospinal fluid in Parkinson's disease: "Dangerous liaisons" on the road to neurodegeneration? 24
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 23
The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis 23
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 23
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers 20
CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases 18
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease 18
Research advancement in fluid biomarkers for Parkinson's disease 18
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment 7
Studying Alzheimer's disease through an integrative serum metabolomic and lipoproteomic approach 2
Totale 1.292
Categoria #
all - tutte 7.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 4 16 3 0 0 0 0 3 7
2021/202264 1 10 2 0 2 5 4 13 4 7 7 9
2022/2023259 9 60 8 17 19 22 0 20 91 1 8 4
2023/2024223 10 16 12 6 7 1 34 6 49 11 27 44
2024/2025680 7 55 51 37 54 44 55 66 115 43 101 52
2025/202633 33 0 0 0 0 0 0 0 0 0 0 0
Totale 1.292